Jun. 21, 2016
Fujifilm Corporation has signed a license agreement concerning Favipiravir, an effective ingredient of its anti-influenza drug “Avigan Tablet 200mg”, with China's Zhejiang Hisun Pharmaceutical Co., Ltd.
Under this agreement, Fujifilm grants Hisun Pharmaceutical a license to develop, manufacture and market the anti-influenza drug in China. Fujifilm will receive a lump-sum payment and royalties once the drug is successfully introduced to the market.